If the U.S. NIH budget had been 40% smaller—similar to cuts proposed in the FY2026 budget—how would that have affected the medicines we enjoy today?
In a new #SciencePolicyArticle, researchers present an analysis of a hypothetical alternative history. https://t.co/NteUnMSF5V
Huge thank you to @TheAAES and @ThyCaInc for funding our research on RAI-resistant thyroid cancer! I am also grateful to the team at @AlbanyMed, especially my co-investigator Dr. John Lamar, without whom this project would not be possible. Time to get to work!
Featured: This review discusses several of the influential studies from the past two decades that have impacted management of patients with differentiated thyroid cancers, including a shift towards more personalized care. @TUllmannMD
https://t.co/pQvBBW9fhl
@SyedAAhmad5
New weekly @AnnSurgOncol featured article: The Landmark Series: Extent of Surgery for Low-Risk Differentiated Thyroid Cancer. Ullmann, T.M., Sosa, J.A.
https://t.co/jH7eRB53Ou #ASOFeaturedArticle
“No government—regardless of which party is in power—should dictate what private universities can teach, whom they can admit and hire, and which areas of study and inquiry they can pursue.”
👏👏👏 @Harvard https://t.co/BeJmKdJXUb
‼️We are pleased to share that Dr. @MattSkovgard will be joining @UCSF as our newest #Thoracic Surgeon and Assistant Professor of Clinical Surgery following the completion of his #Cardiothoracic fellowship at @MSKCancerCenter🎉 Happy Friday Indeed‼️
From @JAMAOto: Among patients planned for total thyroidectomy who developed first side loss of neuromonitoring signal, outcomes of immediate total thyroidectomy and staged surgery were similar.
https://t.co/sIeogLP4S8
Join us in welcoming Dr. Bashir Al Hussein Al Awamlh (@BashirAlHussein) to @WeillCornell@nyphospital! We are so excited to have you on the team.
To learn more about Dr. Al Hussein Al Awamlh and his expertise in the field of urologic oncology, visit https://t.co/VMLXaxcpTV
Study of 18 atypical parathyroid adenomas showed mutations in MEN1, PIK3CA, and CASR but not CDC73. There were no recurrences after short-term followup. This supports the theory that atypical parathyroid adenomas are predominantly benign. https://t.co/9VZEJBmZWh
Which is better for surgical residents: research after PGY2 or PGY3? Check out this recent paper by Egan et al. @CaitlinEgan18 @JohnStratigis
https://t.co/Jay9eMaR9p